De aandelen van Novo Nordisk stonden maandag onder druk nadat de farmaceutische reus uit Denemarken nieuwe ...

After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...

Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...

One of the losers of today's trading session was Novo Nordisk A/S. Shares of the Pharmaceutical company plunged -9.8%, and some investors may be wondering if its price of $78.63 would make a good ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...

Novo Nordisk A/S and Sanofi ... the diabetes and weight-loss products.” Aspen is adding the ability to make pens and may yet get rights to manufacturer insulin pens, Saad added.

March 4, 2025 South African watchdog probes Novo Nordisk and Sanofi over insulin South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti ...

In an exclusive conversation with Business Today, Camilla Sylvest, Executive Vice President, Commercial Strategy & Corporate ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Assess today's live Novo Nordisk A/S Class B (NOVOb) share price, performance and insights using our live Copenhagen: NOVOb stock exchange data. Analyse the historical data and Novo Nordisk A/S Class ...